Acting in an ethical and responsible manner for the patient

Sanofi-aventis acts in an ethical and responsible manner to be a true healthcare partner, today and tomorrow. Our sustainability approach places the patient at the center of our business conduct. It is based on 4 key areas: Patient 21, People 21, Ethics 21 and Planet 21, which are in line with the « Agenda 21 » of the United Nations.

Zoom

Access to medicines

Most of the global population has little or no access to the most basic medicines. In response to this issue, sanofi-aventis has taken proactive steps to make access to healthcare an important part of our strategy for people living in developing as well as industrialized countries.

• For more information about access to medicines in developing countries
• Fore more information about access to medicines in industrialized countries

Pharmaceuticals in the environment

In its commitment to sustainable development, the sanofi-aventis Group has initiated programs to improve risk assessments and considers this challenge to be a priority.

• For more information about pharmaceuticals in the environment

Innovation and ethics in R&D

Conducting research in a context of transparency, with respect for both individuals and regulations.

• For more information about innovation and ethics in R&D

Highlights

60ème anniversaire de la Déclaration Universelle des Droits de l’Homme Sanofi-aventis reiterates its commitment For more information

September 22, 2008

• Sanofi-aventis strengthens its position in the Dow Jones Sustainability World Index

The experts’ corner

Our environmental, social and economic indicators

All our publications Sustainability Report 2007 Sustainability brochure